Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
We found that transcripts for SCP1 could be detected in 10% of myeloma, 5.7% of acute myeloid leukaemia and 23% of chronic myeloid leukaemia.
|
10584877 |
1999 |
Myeloid Leukemia, Chronic
|
0.010 |
Biomarker
|
disease |
BEFREE |
We found that transcripts for SCP1 could be detected in 10% of myeloma, 5.7% of acute myeloid leukaemia and 23% of chronic myeloid leukaemia.
|
10584877 |
1999 |
Multiple Myeloma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We found that transcripts for SCP1 could be detected in 10% of myeloma, 5.7% of acute myeloid leukaemia and 23% of chronic myeloid leukaemia.
|
10584877 |
1999 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
The SCP-1-like gene and cTAGE-1 were shown to be immunogenic and immunologically tumor-specific and may therefore be candidates for immunotherapy targeting CTCL.
|
11149944 |
2001 |
Lymphoma, T-Cell, Cutaneous
|
0.020 |
Biomarker
|
disease |
BEFREE |
The SCP-1-like gene and cTAGE-1 were shown to be immunogenic and immunologically tumor-specific and may therefore be candidates for immunotherapy targeting CTCL.
|
11149944 |
2001 |
synovial sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To shed more light on the etiology of spermatocytic seminomas, we undertook an immunohistochemical and molecular approach using SCP1 (synaptonemal complex protein 1), SSX (synovial sarcoma on X chromosome), and XPA (xeroderma pigmentosum type A) as targets.
|
11454979 |
2001 |
Xeroderma Pigmentosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To shed more light on the etiology of spermatocytic seminomas, we undertook an immunohistochemical and molecular approach using SCP1 (synaptonemal complex protein 1), SSX (synovial sarcoma on X chromosome), and XPA (xeroderma pigmentosum type A) as targets.
|
11454979 |
2001 |
Adult Synovial Sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To shed more light on the etiology of spermatocytic seminomas, we undertook an immunohistochemical and molecular approach using SCP1 (synaptonemal complex protein 1), SSX (synovial sarcoma on X chromosome), and XPA (xeroderma pigmentosum type A) as targets.
|
11454979 |
2001 |
Childhood Synovial Sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To shed more light on the etiology of spermatocytic seminomas, we undertook an immunohistochemical and molecular approach using SCP1 (synaptonemal complex protein 1), SSX (synovial sarcoma on X chromosome), and XPA (xeroderma pigmentosum type A) as targets.
|
11454979 |
2001 |
Lymphoma, T-Cell, Cutaneous
|
0.020 |
Biomarker
|
disease |
BEFREE |
SCP-1 might serve as an additional diagnostic indicator in early and clinically indistinct lesions suspicious for cutaneous T-cell lymphoma.
|
11807795 |
2002 |
Parapsoriasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
From a panel of eleven CTA (MAGE-1, MAGE-C1, MAGE-3, BAGE, GAGE, SSX-1, SSX-2, SSX4, SCP-1, NY-ESO-1 and TS85) (HOM-Tes-85), mRNA expression could be detected for SCP-1 in 8/17 MF and 6/8 pleomorphic CTCL patients but was completely absent in small plaques parapsoriasis.
|
11807795 |
2002 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
SCP-1 was found in only one specimen and a several antigens could not been detected in any tumor tissue or cell line (MAGE-B, GAGE-1,2,8 and all 4 RAGE genes).
|
12584747 |
2003 |
Adenocarcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Pancreatic Neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Adenocarcinoma, Basal Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Adenocarcinoma, Oxyphilic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Carcinoma, Cribriform
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Carcinoma, Granular Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Adenocarcinoma, Tubular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Malignant neoplasm of pancreas
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
|
14991579 |
2004 |
Malignant neoplasm of testis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
In order to define antigens that might be suitable as vaccines for pancreatic carcinoma, we investigated the composite expression of 10 cancer testis (CT) antigens (SCP-1, NY-ESO-1, SSX-1, SSX-2, SSX-4, GAGE, MAGE-3, MAGE-4, CT-7 and CT-8) by Reverse Transcriptase-PCR (RT-PCR) in fresh biopsies of human pancreatic adenocarcinoma, chronic pancreatitis and pancreatic carcinoma cell lines.
|
14991579 |
2004 |
Precancerous Conditions
|
0.010 |
Biomarker
|
group |
BEFREE |
While SCP-1 and GAGE were absent in normal pancreas, they were found in 2/8 (SCP-1) and 1/8 (GAGE) samples of chronic pancreatitis, respectively, supporting the concept of chronic pancreatitis as a premalignant condition.
|
14991579 |
2004 |
Pancreatitis, Chronic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Whether SCP-1 and GAGE expression identify cases of chronic pancreatitis with a high risk of malignant transformation remains to be shown.
|
14991579 |
2004 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SCP-1 and GAGE represent promising candidates for vaccine development in pancreatic carcinoma.
|
14991579 |
2004 |
Malignant transformation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Whether SCP-1 and GAGE expression identify cases of chronic pancreatitis with a high risk of malignant transformation remains to be shown.
|
14991579 |
2004 |